Onn A - Search Results

1

Overcoming molecular mechanisms of resistance to first-generation epidermal growth factor receptor tyrosine kinase inhibitors.

Bar J, Onn A. Bar J, et al. Among authors: onn a. Clin Lung Cancer. 2012 Jul;13(4):267-79. doi: 10.1016/j.cllc.2011.09.001. Epub 2011 Dec 9. Clin Lung Cancer. 2012. PMID: 22154113

2

Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer.

Onn A, Correa AM, Gilcrease M, Isobe T, Massarelli E, Bucana CD, O'Reilly MS, Hong WK, Fidler IJ, Putnam JB, Herbst RS. Onn A, et al. Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):136-43. doi: 10.1158/1078-0432.ccr-0373-3. Clin Cancer Res. 2004. PMID: 14734462

3

Potential role of molecularly targeted therapy in the management of advanced nonsmall cell lung carcinoma in the elderly.

Gridelli C, Massarelli E, Maione P, Rossi A, Herbst RS, Onn A, Ciardiello F. Gridelli C, et al. Among authors: onn a. Cancer. 2004 Oct 15;101(8):1733-44. doi: 10.1002/cncr.20572. Cancer. 2004. PMID: 15386339 Free article. Review.

4

Epidermal growth factor receptor tyrosine kinase inhibitor does not improve paclitaxel effect in an orthotopic mouse model of lung cancer.

Onn A, Isobe T, Wu W, Itasaka S, Shintani T, Shibuya K, Kenji Y, O'reilly MS, Fidler IJ, Herbst RS. Onn A, et al. Clin Cancer Res. 2004 Dec 15;10(24):8613-9. doi: 10.1158/1078-0432.CCR-04-1241. Clin Cancer Res. 2004. PMID: 15623645

5

Pulmonary dysfunction as a major cause of inoperability among patients with non-small-cell lung cancer.

Baser S, Shannon VR, Eapen GA, Jimenez CA, Onn A, Keus L, Lin E, Morice RC. Baser S, et al. Among authors: onn a. Clin Lung Cancer. 2006 Mar;7(5):344-9. doi: 10.3816/CLC.2006.n.017. Clin Lung Cancer. 2006. PMID: 16640807

6

Targeted therapy of orthotopic human lung cancer by combined vascular endothelial growth factor and epidermal growth factor receptor signaling blockade.

Wu W, Onn A, Isobe T, Itasaka S, Langley RR, Shitani T, Shibuya K, Komaki R, Ryan AJ, Fidler IJ, Herbst RS, O'Reilly MS. Wu W, et al. Among authors: onn a. Mol Cancer Ther. 2007 Feb;6(2):471-83. doi: 10.1158/1535-7163.MCT-06-0416. Mol Cancer Ther. 2007. PMID: 17308046

7

Expression of epidermal growth factor (EGF)/transforming growth factor-alpha by human lung cancer cells determines their response to EGF receptor tyrosine kinase inhibition in the lungs of mice.

Wu W, O'Reilly MS, Langley RR, Tsan RZ, Baker CH, Bekele N, Tang XM, Onn A, Fidler IJ, Herbst RS. Wu W, et al. Among authors: onn a. Mol Cancer Ther. 2007 Oct;6(10):2652-63. doi: 10.1158/1535-7163.MCT-06-0759. Epub 2007 Oct 3. Mol Cancer Ther. 2007. PMID: 17913856

8

Combined anti-proliferative and anti-angiogenic strategies for cancer.

Bar J, Onn A. Bar J, et al. Among authors: onn a. Expert Opin Pharmacother. 2008 Apr;9(5):701-15. doi: 10.1517/14656566.9.5.701. Expert Opin Pharmacother. 2008. PMID: 18345949 Review.

9

Multitargeted inhibitors in lung cancer: new clinical data.

Bar J, Herbst RS, Onn A. Bar J, et al. Among authors: onn a. Clin Lung Cancer. 2008;9 Suppl 3:S92-9. doi: 10.3816/CLC.2008.s.014. Clin Lung Cancer. 2008. PMID: 19419930 Review.

10

Targeted drug delivery strategies to treat lung metastasis.

Bar J, Herbst RS, Onn A. Bar J, et al. Among authors: onn a. Expert Opin Drug Deliv. 2009 Oct;6(10):1003-16. doi: 10.1517/17425240903167926. Expert Opin Drug Deliv. 2009. PMID: 19663628 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters